Over 30 medical societies including the American College of Radiology recently wrote to CMS Administrator Mehmet C. Oz, MD, MBA, to voice their concerns. 

Breast imaging exams are about five times likelier to be canceled than other scan types, while contrast enhanced and ED-related requests were about twice as likely. 

New Zealand-based Wellumio in January announced its expansion into the U.S., laying the groundwork for local clinical trials to test its device.